Improving clinical trials for anal cancer treatment
Official title: Cultivating programmatic efforts to optimize the conduct and implementation of NCI-funded clinical trials
Funded at Vanderbilt University Medical Center · NIH-10976308 · Data updated 2026-11-12
This study is all about finding better treatments for anal cancer, and it's designed for patients who want to help improve care by participating in clinical trials that could lead to new and more effective therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project start | September 18, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $130,426 |
| NIH project number | 1R50CA285499-01A1 |
| Project ID | NIH-10976308 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals diagnosed with anal cancer who are seeking new treatment options.
✕Less likely to help
Patients with non-anal cancers or those who are not eligible for clinical trials may not benefit from this research.
What this research studies
This research focuses on enhancing the design and implementation of clinical trials specifically for anal cancer, led by Dr. Cathy Eng, a prominent figure in gastrointestinal oncology. The project aims to develop new treatment protocols and improve existing ones through rigorous clinical trial methodologies. Patients may benefit from innovative therapies that emerge from these trials, which could lead to better treatment outcomes. The research involves collaboration with national clinical trial networks to ensure comprehensive support and mentorship throughout the process.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and standards of care for patients with anal cancer.
How similar studies have gone: Previous research in similar clinical trial networks has successfully changed treatment standards for anal cancer, indicating a promising approach.
Where this research is happening
-
Vanderbilt University Medical Center
Nashville, United States Active
Researchers
- Principal investigator: Eng, Cathy — Vanderbilt University Medical Center
- Study coordinator: Eng, Cathy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.